Hyperthermia Devices Sales

Hyperthermia Devices Sales Market Outlook

The global hyperthermia devices market is projected to reach approximately USD 700 million by 2035, growing at a robust CAGR of around 6.5% during the forecast period from 2025 to 2035. This growth trajectory is driven by the increasing incidence of cancer worldwide, the rising demand for non-invasive treatment options, and the growing awareness regarding the benefits of hyperthermia treatment in oncology. The advancement in technology, leading to the development of more efficient and effective hyperthermia devices, along with the expanding healthcare infrastructure, further fuels the market's growth. Moreover, increasing research activities aimed at exploring the applications of hyperthermia in diverse medical fields, such as pain management and wound healing, contribute significantly to the market expansion.

Growth Factor of the Market

One of the most significant growth factors for the hyperthermia devices market is the escalating prevalence of cancer globally. The World Health Organization estimates that the number of new cancer cases will rise to over 29 million by 2040, thereby highlighting the urgent need for effective treatment modalities such as hyperthermia. Additionally, the increasing acceptance of combination therapies, where hyperthermia is used alongside chemotherapy and radiotherapy, enhances its therapeutic efficacy and provides a substantial impetus for market growth. Furthermore, technological advancements in hyperthermia devices, including improved energy delivery methods and better temperature control mechanisms, are making treatments safer and more effective, thus attracting a wider patient base. The rise of outpatient treatment options has also prompted hospitals and clinics to adopt hyperthermia devices, reflecting a shift in patient care paradigms. Lastly, growing investments in healthcare research and development aimed at the oncology sector are paving the way for innovative hyperthermia applications, ensuring the ongoing expansion of this market.

Key Highlights of the Market

• The global hyperthermia devices market is expected to reach USD 700 million by 2035, growing at a CAGR of 6.5%.
• Increasing cancer prevalence is driving the demand for effective treatment solutions.
• Technological innovations are enhancing the safety and effectiveness of hyperthermia treatments.
• The integration of hyperthermia with other therapeutic modalities is gaining traction.
• Healthcare infrastructure improvements are facilitating greater access to hyperthermia devices.

By Product Type

Regional Hyperthermia Devices:

Regional hyperthermia devices are specifically designed to treat localized cancerous tissues by applying heat over a broader area of the body. These devices are particularly effective for treating tumors that are situated near the surface of the skin or those that are not deeply seated. The technology leverages sophisticated heating mechanisms to raise the temperature of the affected tissues, which can enhance the effectiveness of chemotherapy and radiotherapy when used in combination. The increasing adoption of these devices in clinical settings is primarily driven by the growing body of evidence supporting their efficacy in oncology, making them a pivotal segment within the hyperthermia devices market.

Whole Body Hyperthermia Devices:

Whole body hyperthermia devices are employed to uniformly raise the body temperature to induce a fever-like state, which has been shown to enhance the immune response against tumors. These devices are often utilized for patients with advanced cancer who require an aggressive approach to treatment. Whole body hyperthermia can also improve the effectiveness of other cancer treatments, leading to increased survival rates. As awareness of the benefits of whole body hyperthermia continues to grow among healthcare professionals and patients alike, this segment is expected to witness substantial growth, thereby bolstering the overall hyperthermia devices market.

Local Hyperthermia Devices:

Local hyperthermia devices focus on raising the temperature of a specific area, typically targeting small, localized tumors. These devices utilize advanced technologies to deliver heat directly to the affected site, minimizing exposure to surrounding healthy tissues. The effectiveness of local hyperthermia in reducing tumor size and enhancing the efficacy of radiation therapy is increasingly being recognized, leading to its growing acceptance in clinical practice. This segment is characterized by continuous innovation, with manufacturers striving to develop more precise and effective devices to meet the evolving needs of oncologists and patients.

External Hyperthermia Devices:

External hyperthermia devices are commonly used to treat superficial tumors and are designed to deliver controlled heat through the skin using various energy sources. These devices are non-invasive and relatively easy to use, making them popular among healthcare providers. The increasing number of clinical studies demonstrating the benefits of external hyperthermia in conjunction with other cancer treatments is driving the growth of this segment. Moreover, the ease of application and patient comfort associated with external hyperthermia devices further enhance their appeal, contributing to their increasing adoption in cancer treatment protocols.

Internal Hyperthermia Devices:

Internal hyperthermia devices are designed to target deeper-seated tumors by delivering heat directly to the internal organs. This approach enables more effective treatment of cancers that are difficult to access with external methods. Internal hyperthermia can be achieved through various techniques, including catheter-based devices or probes positioned near the tumor. The efficacy of internal hyperthermia in providing localized treatment while minimizing damage to surrounding tissues has gained prominence, leading to a growing utilization of these devices in clinical oncology. Continued advancements in internal hyperthermia technologies are expected to further propel this segment's growth in the coming years.

By Application

Cancer Treatment:

Cancer treatment is the primary application driving the hyperthermia devices market, as these devices are increasingly recognized for their ability to enhance the effectiveness of conventional cancer therapies. Hyperthermia works by increasing the temperature of tumor tissues, making cancer cells more susceptible to damage from radiation and chemotherapy. Numerous clinical trials have demonstrated that hyperthermia, when utilized as part of a multi-modal treatment plan, can lead to improved patient outcomes. As a result, with the rising incidence of cancer globally, the demand for hyperthermia devices specifically designed for cancer treatment is expected to significantly grow, thereby solidifying its dominance in the market.

Pain Management:

In addition to oncology, hyperthermia devices are gaining traction in the field of pain management. By applying heat to specific areas of the body, these devices can alleviate pain associated with various conditions, including arthritis, muscle strains, and chronic pain syndromes. The analgesic effects of hyperthermia are attributed to the heat-induced relaxation of muscles, improved blood circulation, and the modulation of pain receptors. As the healthcare community continues to explore and validate the benefits of hyperthermia in pain management, this application segment is expected to experience notable growth, broadening the market's scope beyond cancer treatment alone.

Wound Healing:

Hyperthermia devices are also being explored for their potential role in wound healing, where localized heat is applied to enhance tissue repair and regeneration. By increasing blood flow to the affected area, hyperthermia can accelerate the healing process, making it particularly beneficial for patients with chronic wounds or those recovering from surgical procedures. The growing recognition of hyperthermia’s positive effects on wound healing is driving interest and investment in this area, leading to the development of specialized devices aimed at facilitating faster recovery. As healthcare professionals seek innovative solutions to improve patient outcomes, the application of hyperthermia in wound healing is poised for significant growth in the coming years.

Others:

Beyond cancer treatment, pain management, and wound healing, there are other emerging applications of hyperthermia devices in various medical fields, including physiotherapy and rehabilitation. The ability of hyperthermia to enhance tissue elasticity and promote relaxation makes it a valuable tool in physical therapy settings. Additionally, ongoing research is investigating the role of hyperthermia in treating conditions such as fibromyalgia and chronic fatigue syndrome. The expanding recognition of hyperthermia's benefits across various health sectors is driving innovation and adoption, further contributing to the overall growth of the hyperthermia devices market.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for hyperthermia devices, as they are typically the primary settings for cancer treatment and related therapies. With the rising incidence of cancer, hospitals are increasingly investing in advanced treatment options, including hyperthermia, to enhance patient care and improve treatment outcomes. The presence of specialized oncology units within hospitals facilitates the seamless integration of hyperthermia devices into the existing treatment protocols, thereby driving their adoption. Additionally, hospitals often provide comprehensive services, which include patient education about hyperthermia, further promoting its acceptance as a viable treatment option.

Specialty Clinics:

Specialty clinics focusing on cancer treatment and pain management are emerging as crucial distribution channels for hyperthermia devices. These clinics offer a more personalized approach to patient care and often incorporate complementary therapies alongside conventional treatments. The growing trend of holistic healthcare is encouraging specialty clinics to adopt innovative technologies like hyperthermia, which can provide additional benefits to patients. As awareness of hyperthermia's efficacy spreads among both healthcare providers and patients, the demand for these devices within specialty clinics is expected to grow significantly, contributing to the overall expansion of the market.

Online Sales:

The rise of e-commerce has transformed the distribution landscape for medical devices, including hyperthermia devices. Online sales channels offer convenience and accessibility for healthcare providers looking to purchase hyperthermia equipment. These platforms often provide detailed information, user reviews, and competitive pricing, making it easier for clinics and hospitals to make informed purchasing decisions. Furthermore, online sales channels facilitate the introduction of innovative hyperthermia devices to a broader audience, including international markets that may not have easy access to specialized medical equipment. As the trend towards digitalization in healthcare continues, online sales are expected to become an increasingly important distribution channel for hyperthermia devices.

Others:

Other distribution channels, including direct sales by manufacturers, medical device distributors, and partnerships with healthcare organizations, play a vital role in the hyperthermia devices market. Manufacturers often engage in direct selling to establish strong relationships with healthcare providers, ensuring that they receive adequate training and support for the use of hyperthermia devices. Distributors, on the other hand, facilitate the logistics and supply chain management necessary for getting these devices into the hands of clinicians. Partnerships with healthcare organizations enable manufacturers to expand their reach and leverage the expertise of established networks, further promoting the adoption of hyperthermia devices across various sectors.

By Technology Type

Microwave Hyperthermia Devices:

Microwave hyperthermia devices utilize microwave radiation to heat cancerous tissues selectively. This technology enables deeper penetration into tissues, making it particularly effective for treating tumors that are not easily accessible through surface methods. As a non-invasive treatment option, microwave hyperthermia is gaining traction in oncology, especially when used in combination with conventional therapies like chemotherapy and radiation. The technological advancements in microwave delivery systems enhance the precision and efficacy of treatment, leading to improved patient outcomes. Consequently, this segment is expected to continue growing as more healthcare providers recognize the benefits of microwave hyperthermia in clinical practice.

Ultrasound Hyperthermia Devices:

Ultrasound hyperthermia devices employ focused ultrasound waves to generate heat within targeted tissues, offering a precise method for delivering hyperthermia treatment. This technology excels in its ability to concentrate energy on specific areas, minimizing damage to surrounding healthy tissues. Ultrasound hyperthermia is particularly beneficial for treating tumors located deep within the body, where other methods might be less effective. The increasing body of research supporting the efficacy of ultrasound hyperthermia in augmenting traditional cancer treatments is contributing to the segment's growth. As more clinicians adopt this technology, its role in the hyperthermia devices market is set to expand significantly.

Infrared Hyperthermia Devices:

Infrared hyperthermia devices utilize infrared radiation to induce heat in targeted areas, providing an effective treatment option for superficial tumors and skin conditions. The non-invasive nature of infrared hyperthermia makes it an attractive choice for patients seeking alternative therapies with minimal side effects. Furthermore, the versatility of infrared technology allows for its application in various healthcare settings, including rehabilitation and pain management. As awareness of the benefits of infrared hyperthermia increases, along with ongoing innovations in device design, this segment is expected to see considerable growth, thereby contributing to the overall expansion of the hyperthermia devices market.

Others:

This category encompasses various emerging technologies that contribute to the hyperthermia devices market, including combination devices that integrate multiple forms of energy delivery. These innovations have the potential to enhance the effectiveness of hyperthermia treatment by harnessing the strengths of different modalities. Additionally, ongoing research and development efforts are focused on improving the safety and efficacy of existing hyperthermia technologies, which could lead to the emergence of new product offerings in the market. The continuous evolution of hyperthermia technology is expected to drive interest and investment in this segment, helping to establish it as a viable alternative within the broader landscape of cancer and pain management therapies.

By Region

The North American region is a major contributor to the hyperthermia devices market, primarily driven by the increasing prevalence of cancer and advanced healthcare infrastructure. The United States is at the forefront, accounting for a substantial share of the market due to the presence of a large number of cancer treatment centers and an established network of healthcare providers skilled in administering hyperthermia therapy. Moreover, a growing focus on research and development in the field of oncology is propelling further advancements in hyperthermia technologies. The market in North America is expected to grow at a CAGR of approximately 7% during the forecast period, reflecting the ongoing commitment to improving cancer treatment options.

In Europe, the hyperthermia devices market is experiencing significant growth due to a combination of factors, including increasing awareness of alternative cancer therapies and a supportive regulatory environment for medical devices. Countries such as Germany, France, and the United Kingdom are leading in terms of market share, driven by advanced healthcare systems and ongoing clinical research initiatives. The European market is characterized by a growing acceptance of combination therapies, which further enhances the demand for hyperthermia devices. By 2035, the European market is expected to contribute around 25% to the global hyperthermia devices market, highlighting its critical role in the overall growth trajectory.

Opportunities

One of the most promising opportunities in the hyperthermia devices market lies in the expanding scope of research and development aimed at exploring new applications of hyperthermia technology. As healthcare providers increasingly recognize the benefits of hyperthermia beyond oncology—such as in pain management and wound healing—the potential for market growth expands significantly. Ongoing clinical trials investigating the efficacy of hyperthermia in treating a broader range of conditions can lead to the introduction of innovative devices tailored to meet these emerging needs. This diversification of applications not only opens new avenues for revenue generation but also positions hyperthermia as a versatile tool within the healthcare landscape.

Another key opportunity for the hyperthermia devices market is the rising demand for non-invasive treatment options among patients. As more individuals seek alternatives to traditional surgical procedures and invasive therapies, hyperthermia devices present an attractive solution that can yield effective results with minimal side effects. This shift in patient preferences is prompting manufacturers to invest in developing user-friendly, portable hyperthermia devices suitable for outpatient and home care settings. The growing trend of personalized medicine further supports this opportunity, as tailored hyperthermia treatments can be designed to meet individual patient needs and preferences, enhancing patient satisfaction and adherence to treatment protocols.

Threats

Despite the positive outlook for the hyperthermia devices market, several threats could impact growth. One significant concern is the existence of stringent regulatory requirements for medical devices, which can delay the introduction of new technologies and create barriers for smaller manufacturers trying to enter the market. Compliance with regulatory standards necessitates substantial investments in research, development, and clinical trials, potentially limiting the ability of some companies to compete effectively. Furthermore, the complex nature of obtaining approvals in different regions, such as the United States and Europe, may lead to challenges in market entry and expansion, ultimately affecting overall market growth.

Another threat facing the hyperthermia devices market is the potential for competition from alternative treatment modalities. As the medical landscape evolves, new therapies and technologies may emerge that offer similar or superior benefits compared to hyperthermia. This competition can hinder market penetration and adoption rates, particularly if healthcare providers perceive these alternatives as more effective or easier to implement. Additionally, the economic constraints faced by healthcare systems and patients may lead to prioritization of conventional treatments over emerging technologies like hyperthermia, further complicating the market dynamics.

Competitor Outlook

• EMC2 Therapeutics, Inc.
• BSD Medical Corporation
• Oncotherm GmbH
• Pyrexar Medical, Inc.
• ThermoDox® - Celsion Corporation
• Welcome Trust
• HYPERMED, Inc.
• Indigo-Clean
• HYPER-TRAIL
• RDI Enterprises, Inc.
• TheraBionic, Inc.
• Celularity, Inc.
• HYPER-Q, Inc.
• Medtronic plc
• HYPERTHERMIA, Inc.

The competitive landscape of the hyperthermia devices market is characterized by a mix of established players and emerging companies striving to innovate and capture market share. Major companies are focusing on enhancing their product portfolios through research and development, as well as strategic collaborations to improve device efficacy and broaden their application areas. With a strong emphasis on clinical evidence supporting the use of hyperthermia treatments, these companies are actively engaging in clinical trials to validate their technologies and demonstrate their benefits to healthcare providers. As a result, the market is becoming increasingly competitive, with a growing emphasis on differentiation based on technological advancements, patient outcomes, and overall effectiveness of treatments.

Key players in the hyperthermia devices market are leveraging a variety of strategies to maintain their competitive edge. For instance, EMC2 Therapeutics, Inc. focuses on developing advanced hyperthermia technologies that integrate with existing cancer therapies. BSD Medical Corporation, on the other hand, is recognized for its innovative microwave hyperthermia systems, which are designed to enhance the therapeutic impact of cancer treatments. Companies like Oncotherm GmbH are making strides in the development of unique devices that offer localized and regional hyperthermia treatments, catering to the specific needs of oncologists and patients. As the market evolves, these key players will play a crucial role in shaping the future of hyperthermia therapy.

Additionally, the presence of smaller, innovative companies in the hyperthermia devices market adds further dynamism to the competitive landscape. For example, Pyrexar Medical, Inc. has gained recognition for its commitment to advancing microwave hyperthermia technology, while ThermoDox® by Celsion Corporation focuses on combining hyperthermia with drug delivery systems to maximize therapeutic efficacy. The ability of these companies to adapt and respond to changing market demands will be imperative as the hyperthermia devices market continues to grow and evolve. The increasing collaboration between industry players, healthcare institutions, and research organizations further underscores the importance of innovation and adaptability in this competitive environment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HYPER-TRAIL
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Indigo-Clean
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 HYPER-Q, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Welcome Trust
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 HYPERMED, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Oncotherm GmbH
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Celularity, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 TheraBionic, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 HYPERTHERMIA, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Pyrexar Medical, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 RDI Enterprises, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BSD Medical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 EMC2 Therapeutics, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 ThermoDox® - Celsion Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hyperthermia Devices Sales Market, By Application
    • 6.1.1 Cancer Treatment
    • 6.1.2 Pain Management
    • 6.1.3 Wound Healing
    • 6.1.4 Others
  • 6.2 Hyperthermia Devices Sales Market, By Product Type
    • 6.2.1 Regional Hyperthermia Devices
    • 6.2.2 Whole Body Hyperthermia Devices
    • 6.2.3 Local Hyperthermia Devices
    • 6.2.4 External Hyperthermia Devices
    • 6.2.5 Internal Hyperthermia Devices
  • 6.3 Hyperthermia Devices Sales Market, By Technology Type
    • 6.3.1 Microwave Hyperthermia Devices
    • 6.3.2 Ultrasound Hyperthermia Devices
    • 6.3.3 Infrared Hyperthermia Devices
    • 6.3.4 Others
  • 6.4 Hyperthermia Devices Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Online Sales
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hyperthermia Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hyperthermia Devices Sales market is categorized based on

By Product Type

• Regional Hyperthermia Devices
• Whole Body Hyperthermia Devices
• Local Hyperthermia Devices
• External Hyperthermia Devices
• Internal Hyperthermia Devices

By Application

• Cancer Treatment
• Pain Management
• Wound Healing
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Online Sales
• Others

By Technology Type

• Microwave Hyperthermia Devices
• Ultrasound Hyperthermia Devices
• Infrared Hyperthermia Devices
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• EMC2 Therapeutics, Inc.
• BSD Medical Corporation
• Oncotherm GmbH
• Pyrexar Medical, Inc.
• ThermoDox® - Celsion Corporation
• Welcome Trust
• HYPERMED, Inc.
• Indigo-Clean
• HYPER-TRAIL
• RDI Enterprises, Inc.
• TheraBionic, Inc.
• Celularity, Inc.
• HYPER-Q, Inc.
• Medtronic plc
• HYPERTHERMIA, Inc.